# External Review 3/3

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-17T16:50:32.494514
**OpenAI Response ID:** resp_052e0c74d06e7ebf00696baf3e30008197a7eff1db0319c206
**Tokens:** 17920 in / 5811 out

---

## PHASE 1: FORMAT REVIEW

1. **Length (≥25 pages excl. refs/appendix)**: **PASS**  
   Approx. main text runs to ~pp. 1–35 (Conclusion ends around p. 35), with References starting ~p. 36 and Appendix ~p. 39.

2. **References (≥15 citations)**: **PASS**  
   Bibliography contains ~28 entries.

3. **Prose Quality (no bullets in core sections)**: **PASS**  
   Introduction, Literature Review, Results, and Discussion are written as paragraphs (no bullet formatting in those sections).

4. **Section Completeness (each major section has 3–4 substantive paragraphs)**: **PASS**  
   Introduction, Literature, Data/Methods, Results, and Conclusion are each multi-paragraph and substantive.

5. **Figures (visible data; not broken/empty)**: **PASS**  
   Figures shown (gender bars; event-study panels; stacked composition) contain plotted data with axes/labels.

6. **Tables (real numbers; no placeholders)**: **PASS**  
   Tables display numeric estimates (no “TBD/XXX”).

### PHASE 1 VERDICT
**PHASE 1: PASS - Proceeding to content review**

---

## PHASE 2: CONTENT REVIEW (Top-journal standard; extremely rigorous)

### 1) STATISTICAL METHODOLOGY (NON-NEGOTIABLE)

**Bottom line: the paper’s current inference is not credible for a DiD with one treated state and ~6 state clusters. As written/presented, it is not publishable.**

#### (a) Standard errors reported?
**PASS (mechanically)**: Tables 2 and 3 report SEs in parentheses.

#### (b) Significance testing reported?
**PASS (mechanically)**: Stars and/or p-values are reported.

#### (c) Confidence intervals for main results available?
**WARN**: CIs are computable from point estimates and SEs, but the **SEs appear invalid** (see below), so computed CIs would be misleading.

#### (d) Sample sizes reported?
**PASS**: Tables report N.

#### (e) DiD design / staggered adoption concerns?
**PASS / NOT THE MAIN ISSUE**: Treatment is effectively “one state turns on in 2017/2018.” Classic TWFE bias from staggered timing is not the key problem here (though within-VA rollout is staggered and unobserved, which raises other issues).

#### Core problem: **Inference with few clusters is mishandled and internally inconsistent**
- In **Section 4.4**, the paper acknowledges the “few treated units/few clusters” problem and states it uses **wild cluster bootstrap** and **randomization inference** (good instincts).
- But **Table 2 and Table 3 explicitly report “Robust standard errors”** (not clustered; not wild-bootstrap p-values). With treatment assigned at the **state-policy level**, individual-level “robust” SEs are **well known to be wrong** (Bertrand, Duflo, Mullainathan 2004).
- Even if the authors meant “cluster-robust,” the table does not say that; and with **~6 clusters**, conventional cluster-robust SEs are unreliable anyway. The reported SE magnitudes (e.g., **0.13 minutes** on screen time with outcomes having SDs ~70 minutes) are a major red flag that the regression is treating thousands of individual diaries as quasi-iid, producing **false precision**.

**This is a fatal issue at AER/QJE/Ecta standards.** With one treated state, the effective identifying variation is at the state-by-time level; the paper must present inference that respects that.

**What you must do to be taken seriously:**
1. Make the primary results table report **state-clustered** SEs *and* the **wild cluster bootstrap p-values** (or CIs) you claim to use, clearly labeled.  
2. Add **randomization inference** results in the main text (not just mentioned): e.g., show the distribution of placebo “treated state” effects across the 6 states and report exact/randomization p-values.  
3. Strongly consider collapsing the data to **state×year (or state×year×gender)** means and running the DiD at that level (or at least show it as a robustness check). This makes the level of identifying variation transparent.  
4. Report **joint tests of pre-trends** in the event study (and show SEs/CIs for event-study coefficients).

If these changes substantially widen uncertainty (they likely will), many “*** p<0.01” claims may not survive. Right now, the paper’s statistical certainty is not believable.

---

### 2) Identification Strategy

#### Strengths
- Clear policy motivation: VATI is plausibly a large infrastructure shock (Section 3).
- The paper attempts an **event-study** (Section 5.4), placebo tests (Section 6.2), alternative controls (6.1), and COVID sensitivity (6.3). This is the correct menu.

#### Major concerns
1. **Treatment measured at the state level, but VATI is local and targeted.**  
   You acknowledge this (Section 6.4), but the consequences are deeper:
   - The “treated” group includes many VA teens likely unaffected (urban/suburban already-served). This creates attenuation **and** compositional issues if the ATUS sample’s rural share changes over time differentially in VA.
   - Without county-level identifiers (public ATUS), you need stronger evidence that VA’s *statewide* broadband environment shifted relative to controls in the relevant years (2017–2019).

   **Minimum fix:** Provide **first-stage evidence**: show that broadband availability/adoption increased more in VA than controls in the post period (e.g., FCC Form 477 / BroadbandNow / ACS internet subscription rates) at least at the state-year level.

2. **Control states may have concurrent broadband expansions** (federal CAF, state initiatives, private rollouts).  
   That biases estimates toward zero (maybe), but it also muddies interpretation: you estimate “VA policy bundle vs neighbors,” not “broadband vs no broadband.”

3. **Parallel trends evidence is not reported with proper uncertainty and testing.**  
   Figure 2 shows notable pre-period fluctuation (especially in-person socializing). Table 6 lists pre coefficients but provides **no SEs/CIs** and no joint test. At top journals, you need:
   - event-study coefficients **with** CIs,
   - **joint F-test** of all pre-treatment leads,
   - sensitivity to different omitted/reference years and/or pre-period windows.

4. **Timing ambiguity (2017 vs 2018).**  
   The paper states VATI begins in 2017, but defines Post as 2018+. If 2017 is partly treated, it contaminates the reference period and biases dynamic patterns.

   **Minimum fix:** show sensitivity defining treatment as Post=2017+, excluding 2017, and/or using actual award/connection timing.

5. **Multiple outcomes / multiple testing.**  
   You test 6 outcomes + gender heterogeneity + event studies. At minimum, report sharpened q-values or family-wise error adjustments (or pre-registered primary outcomes with a clear hierarchy). Otherwise the “statistically significant everywhere” pattern is not convincing.

---

### 3) Literature (missing/weak coverage + placeholder citations)

#### Critical issue: **many in-text citations are placeholders (“(?)”, “(??)”)**
This is not acceptable in a journal submission. It prevents readers from verifying factual claims and makes the literature review look unfinished.

#### Key missing references (methodology and inference)
You cite Bertrand et al. (2004) and Conley & Taber (2011) and Cameron et al. (2008), which is good. But given your design, you should also cite and/or use:

```bibtex
@article{MacKinnonWebb2017,
  author = {MacKinnon, James G. and Webb, Matthew D.},
  title = {Wild Bootstrap Inference for Wildly Different Cluster Sizes},
  journal = {Journal of Applied Econometrics},
  year = {2017},
  volume = {32},
  number = {2},
  pages = {233--254}
}

@article{FermanPinto2019,
  author = {Ferman, Bruno and Pinto, Cristine},
  title = {Inference in Differences-in-Differences with Few Treated Groups and Heteroskedasticity},
  journal = {Review of Economics and Statistics},
  year = {2019},
  volume = {101},
  number = {3},
  pages = {452--467}
}

@article{GoodmanBacon2021,
  author = {Goodman-Bacon, Andrew},
  title = {Difference-in-Differences with Variation in Treatment Timing},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  number = {2},
  pages = {254--277}
}

@article{SunAbraham2021,
  author = {Sun, Liyang and Abraham, Sarah},
  title = {Estimating Dynamic Treatment Effects in Event Studies with Heterogeneous Treatment Effects},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  number = {2},
  pages = {175--199}
}
```

Even if you argue staggered timing bias is not central here, **Sun–Abraham** style event-study estimation is still relevant if effects are heterogeneous and you are plotting dynamics.

#### Key missing domain literature (internet expansion + youth)
You cite Malamud & Pop-Eleches (2011), Fairlie & Robinson (2013), Vigdor et al. (2014), Dettling et al. (2018)—good. But major related work on broadband/internet and social outcomes/time use is thin, and several factual claims cite “(?)”.

Consider adding (examples; verify details/fit):
- Broadband and social capital / social outcomes: e.g., additional papers building on Bauernschuster et al. (2014).
- Social media and mental health causal evidence (if you discuss well-being trends): e.g., Allcott et al. on Facebook deactivation/welfare, Braghieri et al. on Facebook rollout and mental health (if you go there—right now you mostly stick to time use, which is fine).

---

### 4) Writing / exposition quality

- Generally clear structure, readable, and the contribution is stated early.
- However, credibility is undermined by:
  1) placeholder citations (“(?)”, “(??)”), and  
  2) the mismatch between claimed inference methods (wild bootstrap / randomization inference) and what is actually reported (“robust SEs”).

Also, several claims are too strong given measurement:
- “first quasi-experimental evidence” is likely overstated unless you carefully delimit to **ATUS diary-based time allocation** and **this policy context**.

---

### 5) Figures and Tables (quality and scientific adequacy)

**Presentation is mostly fine** (labels, axes, readable).

But scientifically:
- Event-study figure must show **correct uncertainty** (and computed using valid inference). With few clusters, conventional 95% CIs are not reliable; consider wild-bootstrap-based bands or randomization-inference-based intervals.
- Table 2 p-values reported as “0.000” is not publication style and also suggests mechanical precision from invalid SEs. Report p-values with sensible rounding and specify their source (wild bootstrap vs asymptotic).

---

### 6) Overall Assessment (AER/QJE/Ecta standard)

#### Strengths
- Important question with direct policy relevance (broadband expansion and teen behavior).
- ATUS time diaries are a strong measurement tool for time allocation.
- Clear attempt at modern policy evaluation toolkit (DiD + event study + placebo/robustness sections).

#### Critical weaknesses (would trigger rejection in current form)
1. **Inference is not credible** for a one-treated-state DiD; tables report “robust” SEs that likely produce severe overrejection.  
2. **No demonstrated first-stage** that VATI materially changed broadband access/adoption in VA relative to controls in the analysis window.  
3. **Parallel trends not convincingly established** (no SEs/joint tests for leads; pre-period volatility).  
4. **Citations are incomplete** (placeholders).

#### What would make it publishable (major revision)
- Rebuild the empirical section around **design-consistent inference** (wild cluster bootstrap, randomization inference, Conley–Taber-style approaches), and report those results in the main tables.
- Add state-year broadband penetration/adoption evidence (first stage).
- Tighten event-study validation (lead tests, alternative windows, sensitivity to treatment date).
- Resolve placeholder citations and strengthen the literature positioning.
- Pre-specify (or justify) a primary outcome set and adjust for multiple testing.

**Recommendation:** **Reject / Major revision required**. The research question is promising, but until the inference and identification validation are corrected and transparently reported, the numerical findings and “statistical significance everywhere” pattern are not scientifically reliable.